⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BRNS News
Barinthus Biotherapeutics plc American Depositary Shares
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
globenewswire.com
BRNS
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
BRNS
FITB
ADVM
HBAN
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
prnewswire.com
NIC
AKRO
BRNS
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
globenewswire.com
BRNS
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
prnewswire.com
BRNS
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates SWKH, ETNB, BRNS, VRNT on Behalf of Shareholders
prnewswire.com
SWKH
ETNB
BRNS
VRNT
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ETNB, TRML, CORZ, BRNS on Behalf of Shareholders
prnewswire.com
ETNB
TRML
CORZ
BRNS
BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS
businesswire.com
BRNS
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
globenewswire.com
BRNS
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
globenewswire.com
BRNS